Cosentyx
 (secukinumab):
 75 mg/0.5 mL
 syringe

 1 syringe
 per 28 days

 5 syringes
 per 35 days

 PsA/AS/axSpA:
 •    Loading doses (optional):
      150 mg at weeks 0, 1, 2, 3, 4
 •    Maintenance dose:
      150 mg every 4 weeks
 •    Continued active PsA/AS:
       300 mg every 4 weeks

 Plaque psoriasis in adults, with
 or without coexistent psoriatic
 arthritis:
 •    Loading doses:
       300 mg at weeks 0, 1, 2, 3, 4
 •    Maintenance dose:
       300 mg every 4 weeks
       (150 mg every 4 weeks may
       be acceptable)

 Pediatric Plaque Psoriasis (6
 years and up):
 •    < 50 kg: Loading doses of 75
       mg at weeks 0, 1, 2, 3, and 4
       and maintenance dose of 75
       mg every 4 weeks
 •    > 50 kg: Loading doses of 150
      mg at weeks 0, 1, 2, 3, and 4
      and maintenance dose of 150
      mg every 4 weeks

 Enthesitis-Related Arthritis (4
 years and up):
 •    ≥ 15 kg and < 50 kg: Loading
       doses of 75mg at weeks 0, 1,
       2, 3.and 4 and maintenance
       dose of 75 mg every 4 weeks
 •     ≥ 50 kg: Loading dose of
       150mg at weeks 0,1, 2, 3 and
       4 and maintenance dose of
       150mg every 4 weeks

 Cosentyx
 (secukinumab):
 150 mg/mL
 pen or syringe

 1 pen/syringe
 per 28 days

 5 pens/syringes
 per 35 days

 Cosentyx
 (secukinumab):
 300 mg dose
 carton   containing (2)
 150 mg/mL
 pens or (2) 150
 mg/mL syringes

 1 dose carton
 per 28 days

 5 dose cartons
 per 35 days